Summary
Forty-six patients with advanced head and neck squamous cell carcinomas received two courses of chemotherapy with cisplatinum and bleomycin before undergoing cancer surgery. After surgery, histological serial sections of the resection specimens were examined. Biopsies from each resected specimen were shock-frozen for immunohistochemical examinations using the monoclonal antibodies Ki-67 and RPN-511, which are associated with cell proliferation. In no case did the morphologic analysis demonstrate complete tumor regression after chemotherapy. Thirty-seven patients showed partial tumor regressions histologically, as seen by tumor shrinkage of more than 50%. Nine of the specimens showed only minor regressions, with shrinkage less than 50%. The immunostaining of the frozen sections revealed in all cases the expressions of the Ki-67 nuclear antigen and the presence of specific transferrin (RPN-511) receptors in the proliferative compartments of the carcinomas.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bettinger R, Meyer-Breiting E, Klima A (1987) Patho-histologische Serienschnittuntersuchungen nach zytostatischer Induktionstherapie von Plattenepithelkarzinomen der Mundhöhle und des Oropharynx. Arch Otorhinolaryngol 244 [Suppl 2]:244–245
Boeheim K, Spoendlin H (1983) The effect of chemotherapy in relation to pathohistological tumour grading in head and neck cancer. Arch Otorhinolaryngol 238:197–204
Boeheim K, Mikuz G, Boeheim C (1982) Pathohistologische Veränderungen nach zytostatischer Induktionstherapie mit Metotrexat (M), Bleomycin (B) und Cis-Platinum (P)- (MBP) Laryngol Rhinol Otol 61:246–250
Burkhardt A, Bummer G, Gebbers J, Höltje B (1976) Riesenzellbildung bei Bleomycintherapie oraler Plattenepithel-karzinome. Virchows Arch A Pathol Anat Histol 369:197–214
Drewindo B, Green C, Loo TI (1976) Combination chemotherapy in vitro with cis-dichlorodiamineplatinum (2). Cancer Treat Rep 60:1619–1623
Ganzer U (1978) Zellkinetische Untersuchungen zum Wirkungsmechanismus des Zytostatikums Bleomycin. Laryngol Rhinol 57:177–186
Gatter K, Brown G, Trowbridge I, Woolston R-E, Mason D (1983) Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol 36:539–545
Gerdes J, Lemke H, Baisch H, Wacker H, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710–1715
Goldie J, Coldman A (1979) A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63:1727–1733
Hong W, Stanley M, Shapshay S, Bhutani R, Craft M, Ucmakli A, Yamaguchi K, Vaughan C, Strong M (1979) Induction chemotherapy in advanced squamous head and neck carcinoma with high dose cisplatinum and bleomycin infusion. Cancer 44:19–25
Kish J, Ensley J, Weaver A, Jacobs J, Cummings G, Al-Sarraf M (1984) Improvement of complete response rate to induction adjuvant chemotherapy for advanced squamous cell carcinoma of the head and neck. In: Jones (ed) Adjuvant therapy of cancer, vol 4. Elsevier, Amsterdam, pp 107–115
Klima A, Ilberg Ch von, Bergmann L, Zoubek A, Klippstein T, Mitrou S, Szepesi S (1987) Chemotherapie oder Chemotherapie und Strahlentherapie bei weft fortgeschrittenen Kopfund Halstumoren. HNO 35:78–83
Loerz M, Meyer-Breiting E (1988) Evaluation of proliferative activity in human head and neck tumors using the monoclonal antibody Ki-67. ORL 50:183–187
14.Mason D (1985) Immunohistochemical labeling of monoclonal antibodies by the APAAP immunoalkaline phosphatase technique. In: Bullock, Petrusz (eds) Techniques in immunocytochemistry, vol 2. Academic Press, New York, pp 25–40
Peppard S, Al-Sarraf M, Powers W, Loh J, Weaver A (1980) Combination of cis-platinum, oncovin, and bleomycin prior to surgery and/or radiotherapy in untreated epidermoid cancer of the head and neck. Laryngoscope 90:1273–1280
asaki K, Murakami T, Kawasaki M, Takahashi M (1987) The cell cycle associated change of the Ki-67 reactive nuclear antigen expression. J Cell Physiol 133:579–584
Shapshay S, Hong W, Incze J, Yamaguchi K, Bhutani R, Vaughan C, Strong M (1978) Histopathologic findings after cisplatinum bleomycin therapy in advanced previously untreated head and neck carcinoma. Am J Surg 136:534–538
Shaw H, Price L, Hill B (1984) Treatment of advanced squamous cell carcinomas of the head and neck with initial combination chemotherapy prior to surgery and/or radiotherapy. Five year survival data. J Laryngol Otol 98:75–82
Shindelman J, Ortmeyer A, Sussman H (1981) Demonstration of the transferrin receptor in human breast cancer tissue. Potential marker for identifying dividing cells. Int J Cancer 27: 329–334
Umezawa H, Maeda K, Takeuchi T, Okami J (1966) New antibiotics: bleo-mycin A and B.J. Antibiot Tokyo 19:200–213
Weidauer H, Singer R (1981) Ergebnisse einer primaren antineoplastischen Chemotherapie bei fortgeschrittenen verhornenden Plattenepithelcarcinomen im Kopf-Hals-Bereich. Laryngol Rhinol 60:151–161
Author information
Authors and Affiliations
Additional information
Offprint requests to: R. Bettinger
Rights and permissions
About this article
Cite this article
Bettinger, R., Loerz, M. & Meyer-Breiting, E. Proliferative activity following induction chemotherapy in squamous cell carcinoma of the head and neck. Eur Arch Otorhinolaryngol 248, 236–241 (1991). https://doi.org/10.1007/BF00173663
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00173663